What are the clinical indications for performing a PET/CT scan?

PET/CT Scan Clinical Indications

PET/CT is primarily indicated for oncologic applications including staging, restaging, response assessment, and recurrence detection in specific cancer types, with emerging roles in infection/inflammation, cardiovascular disease, and neurological disorders.

Primary Oncologic Indications

High-Value Cancer Applications

The following malignancies represent the strongest evidence base for PET/CT utilization 1, 2:

• Lung cancer: Accounts for 26% of clinical PET/CT scans, with primary use in staging (62%) and recurrence detection (10%) 2
• Lymphoma/Hematologic malignancies: Represents 12% of scans, with substantial use in response evaluation (36%) and staging (19%) 2
• Colorectal cancer: Comprises 9% of scans, predominantly for staging (61%) and recurrence detection (15%) 2
• Head and neck cancers: 4% of scans, used for diagnosis (31%), staging (24%), and recurrence surveillance (29%) 2
• Melanoma: 4% of scans, with emphasis on recurrence detection (45%) and staging (30%) 2
• Breast cancer: Established role in staging and restaging 3, 4

Gynecologic Malignancies

PET/CT use in gynecologic cancers shows variable patterns 2:

• Ovarian cancer: 4% of scans, primarily for diagnosis (59%) and staging (15%) 2
• Cervical cancer: 3% of scans, with balanced use across recurrence detection (33%), staging (33%), and diagnosis (21%) 2
• Uterine cancer: 1% of scans, mainly for recurrence (32%) and staging (30%) 2

Esophageal Cancer

• Proven utility in staging and restaging 3

Non-Oncologic Indications

Infection and Inflammation

[18F]FDG PET/CT is indicated for infectious and inflammatory conditions in adults, with specific protocols optimized for these applications 1:

• Prosthetic joint infection (PJI): Limited field-of-view imaging can be confined to one or two positions 1
• Diabetic foot infection: Targeted imaging protocol with inclusion of lower extremities to the feet 1
• Infection of unknown origin: Whole-body assessment for occult infectious foci 2
• Musculoskeletal infections: Requires thin-slice CT acquisition with bone matrix reconstruction in orthogonal planes 1
• Inflammatory conditions: General inflammatory disease assessment 2

Cardiovascular Applications

• Delayed dedicated static imaging (>90 minutes post-injection) with cardiac gating improves diagnostic accuracy for cardiac indications 1
• Expected to potentially replace myocardial scintigraphy 2

Neurological Disorders

• Established role in select neurological conditions 2

Technical Specifications for Optimal Imaging

Radiopharmaceutical Administration

• Uptake period: Minimum 60 minutes between [18F]FDG injection and acquisition; preferred uptake period of 90 minutes 1
• Effective radiation dose: 1.9×10⁻² mSv/MBq for [18F]FDG, plus additional CT exposure 1

Field of View Considerations

• Standard whole-body: Head to upper thighs, completed in <20 minutes 4
• Extended lower extremity: Include feet when lower extremity involvement suspected 1
• Upper extremity: Include when clinically relevant 1
• Limited FOV: Appropriate for specific indications like PJI or diabetic foot 1

Advanced Technology Applications

• Total-body PET/CT systems: Enable single-step whole-body imaging in critically ill and debilitated patients with suspected infectious processes 1
• Spatial resolution: Approaches 2-4mm 4
• Reduced radiation exposure: Recent technological advances allow decreased injected activity and/or acquisition duration while maintaining image quality 1

Diagnostic Performance Metrics

Overall Oncologic Accuracy

• Sensitivity: 84% across all oncology applications (based on 18,402 patient studies) 2
• Specificity: 88% across all oncology applications (based on 14,264 patient studies) 2
• Management change: Average 30% across all applications (range 25-43% in various studies) 2

Cancer-Specific Accuracy

• Average accuracy ranges between 87-94% for the six major cancer types 2

Critical Interpretation Considerations

Positive Study Criteria

• Increased uptake intensity higher than surrounding background 1
• Uptake not explained by physiological activity 1
• Correlation with CT morphologic data essential 1

False-Negative Causes

Even with negative PET findings, thorough CT evaluation is essential 1:

• Small lesion size 1
• Location adjacent to physiologic uptake 1

Musculoskeletal-Specific Findings

• CT assessment required for signs of acute and chronic osteomyelitis 1
• Evaluate for fracture, arthropathy, metastases, and degenerative changes as differential diagnoses for increased uptake 1

Common Pitfalls

Artifact Management

• Metallic artifact reduction techniques: Should be used whenever available and indicated 1
• Close attention to protocol details and patient immobilization reduces artifact frequency 5

Lymph Node Interpretation

• Radiotracer avidity in locoregional lymph nodes suggested as predictor of infection but should be used with caution as its role as specific interpretation criterion is not established 1